Feed

Latest Intelligence

Every AI development we have covered, newest first. Filter by section to focus on what matters to you.

MIT Technology ReviewAug 25, 2026Business

I spent a day at a robot “carnival” in Shanghai. Here’s what I saw.

China is accelerating the commercialization and deployment of humanoid robotics and embodied artificial intelligence, driven by national industrial policy outlined in its latest five-year plan. Reporting from a robotics showcase in Shanghai highlights rapid expansion in domestic manufacturing, with Chinese firms establishing substantial global supply chain dominance in physical AI systems. The sector is transitioning from theoretical models to physical machines designed to integrate artificial intelligence into industrial operations and daily environments.

40/100

Ars TechnicaAug 24, 2026Business

AI is hitting entry-level jobs hardest, Stanford study finds

A Stanford University research study reveals that artificial intelligence adoption is disproportionately reducing entry-level employment. According to the study reported by Ars Technica, employment among younger workers in AI-exposed occupations experienced a 19 percent decline compared to roles more resistant to automation. The findings indicate that organizations are increasingly utilizing AI systems to automate introductory and task-oriented responsibilities, significantly altering early-career hiring pipelines across impacted knowledge-work sectors.

30/100

The RegisterAug 24, 2026Enterprise

Canonical backs quest to translate mountains of C into safe Rust with AI

Canonical is funding academic research at the University of Bristol to evaluate the feasibility of using artificial intelligence to automatically translate mature C codebases into memory-safe Rust. The initiative aims to determine whether complex, real-world systems software can maintain functional correctness and stability when migrated via machine-driven translation. While manual rewrites to Rust are notoriously resource-intensive, successful automated translation could significantly reduce the cost and technical risk associated with modernizing mission-critical open source and enterprise infrastructure.

38/100

TechCrunchAug 23, 2026Models

Who’s behind the new ‘stealth model’ Ox Alpha?

Speculation has emerged surrounding a newly surfaced stealth artificial intelligence model named Ox Alpha, following its appearance in developer and benchmarking circles such as OpenRouter. The identity of the underlying developer, architectural specifications, deployment timeline, and technical benchmarks remain unconfirmed publicly. Industry observers are analyzing early telemetry and output characteristics to determine whether the model originates from an established frontier AI lab or an emerging independent research team.

18/100

TechCrunchAug 22, 2026Models

Inherent, founded by DeepMind alumni, says its AI ‘teammate’ just outperformed Anthropic and OpenAI at replicating research

British startup Inherent, founded by former Google DeepMind researchers, has introduced Faraday, an AI agent designed to replicate scientific research papers. The company claims the tool outperforms frontier models from OpenAI and Anthropic in scientific replication workflows. The system is positioned as an AI collaborator to accelerate scientific discovery and validate published findings, though the comparative performance metrics currently reflect vendor-reported evaluations rather than independent peer review.

23/100

TechCrunchAug 22, 2026Regulation

Frontier AI labs still won’t say how they’d contain a rogue model

A newly published study indicates that major frontier artificial intelligence developers lack comprehensive, publicly documented containment protocols for rogue or misaligned models. While leading organizations continue to advance frontier model capabilities and autonomous agents, the research highlights a systemic deficit in transparent incident response frameworks designed to halt or isolate models demonstrating unintended, high-risk, or uncontrollable behaviors during operation.

39/100

TechCrunchAug 21, 2026Enterprise

Nvidia just showed that the harness, not the AI model, is now the real hero

Nvidia published research demonstrating that structured agent harnesses and targeted fine-tuning enable AI agents to perform reliably, even when powered by less capable underlying foundation models. The study highlights that execution scaffolding, guardrails, and task-specific tuning effectively prevent agent drift and hallucination during multi-step tasks. This approach demonstrates that engineering the surrounding software architecture can compensate for limitations in baseline model size and capability.

40/100

MIT Technology ReviewAug 21, 2026Business

The Download: threats from space mirrors and credit for AI drugs

MIT Technology Review highlights emerging debates regarding intellectual property attribution and scientific credit for pharmaceuticals developed using artificial intelligence. As computational platforms take on greater roles in identifying and optimizing candidate molecules, life sciences organizations face growing ambiguity over patent inventorship requirements, balancing contributions between human researchers and generative design algorithms across drug discovery pipelines.

21/100

Google DeepMindAug 21, 2026Business

From Atari to EVE Online: Building on 15 Years of AI Research in Games

Google DeepMind announced partnerships with commercial game studios to prototype novel AI-driven gameplay systems, building upon 15 years of game-focused research spanning Atari benchmarks to complex virtual environments like EVE Online. The initiative marks a transition from evaluating reinforcement learning models in isolated academic tests to applying advanced AI agents within active gaming environments. DeepMind is collaborating directly with developers to implement real-time multi-agent decision-making and adaptive agent architectures inside commercial game engines.

27/100

MIT Technology ReviewAug 21, 2026Business

When AI designs a drug, who gets the credit?

Biotechnology companies such as Insilico Medicine are leveraging generative AI platforms to design novel therapeutic molecules, including candidate treatments for pulmonary fibrosis. As machine learning systems take on primary roles in proposing chemical structures, ambiguity arises over legal inventorship, scientific attribution, and intellectual property eligibility. Global patent authorities and pharmaceutical firms must address how algorithmic drug designs align with traditional legal requirements that mandate human inventorship.

29/100